# Tirupati Medicare Ltd. · 66-41 · INDIA — FDA import alert red lists: firms subject to detention without physical examination For Tirupati Medicare Ltd. · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product is Divisa Natural Laxative Tablets | Divisa Natural Laxative Tablets; product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 10/19/2022; address is Nahan Road , Paonta Sahib, Dist. Simour INDIA, verified against its source on 2026-09-16. - **Firm:** Tirupati Medicare Ltd. _(verified: appears in the quote below)_ - **Import alert:** 66-41 - **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. - **Country:** INDIA _(verified: appears in the quote below)_ - **Address:** Nahan Road , Paonta Sahib, Dist. Simour INDIA _(verified: appears in the quote below)_ - **Date published:** 10/19/2022 _(verified: appears in the quote below)_ - **Product code:** 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_ - **Product:** Divisa Natural Laxative Tablets | Divisa Natural Laxative Tablets _(verified: each item appears in the quote below)_ ## What the source says > Tirupati Medicare Ltd. Date Published : 10/19/2022 Nahan Road , Paonta Sahib, Dist. Simour INDIA 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 10/19/2022 Desc: Divisa Natural Laxative Tablets 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/19/2022 Desc: Divisa Natural Laxative Tablets ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_190.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).